Remedium Lifecare: Board Meeting Intimation for To Consider Un-Audited Financial Results/Statements (Standalone & Consolidated) Of The Company For The Third Quarter And Nine Months Ended December 31 2025 And Update On Trading Window

Supha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/03/2026 inter alia to consider and approve To consider Un-Audited Financial Results/Statements (Standalone & Consolidated) of the Company for the Third Quarter and Nine months ended December 31 2025 and update on Trading Window